Skip to main content
BKYI
NASDAQ Technology

BIO-key 收到 Nasdaq 非合规通知，因 10-K 延迟提交

feedReported by GlobeNewswire
Sentiment info
Negative
Importance info
8
Price
$0.629
Mkt Cap
$6.828M
52W Low
$0.49
52W High
$1.97
Market data snapshot near publication time

summarizeSummary

BIO-key International 收到 Nasdaq的一份非合规通知，这是由于其未能及时提交截至 2025 年 12 月 31 日的年度报告（Form 10-K）。这一发展引入了重大的不确定性，尤其是在最近关于 2026 年上半年收入指导强劲的积极消息之后。虽然这一通知不会立即影响股票的上市，但它引发了人们对公司财务报告和公司治理的担忧。对于像 BIO-key 这样的微型上市公司，这样的合规问题可能会严重影响投资者信心。公司预计下周将提交 10-K，交易者将密切关注其提交和随后关于其与 Nasdaq 合规状态的任何更新。

在该公告发布时，BKYI的交易价格为$0.63，交易所为NASDAQ，所属行业为Technology，市值约为$682.8万。 52周交易区间为$0.49至$1.97。 这则新闻被评估为消极市场情绪，重要性评分为8/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed BKYI - Latest Insights

BKYI
Apr 29, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key International Finalizes 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance
Sentiment: Negative
View Wiseek Article
BKYI
Apr 24, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Stockholders Approve Reverse Stock Split to Address Nasdaq Compliance
Sentiment: Neutral
View Wiseek Article
BKYI
Apr 22, 2026, 4:45 PM EDT
Source: GlobeNewswire
Importance Score:
8
BIO-key Receives Nasdaq Non-Compliance Notice for Delayed 10-K Filing
Sentiment: Negative
View Wiseek Article
BKYI
Apr 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Projects 50% H1 Revenue Growth and Profitability Turnaround
Sentiment: Positive
View Wiseek Article
BKYI
Apr 16, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
BIO-key Forecasts 50% H1 Revenue Surge, Projects Positive Net Income
Sentiment: Positive
View Wiseek Article
BKYI
Mar 31, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Reports Strong Cash Position and Positive 2026 Outlook Despite Q4 EPS Miss
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 31, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
BIO-key Reports Q4 Loss of 19 Cents Per Share, Significantly Missing Estimates
Sentiment: Negative
View Wiseek Article
BKYI
Mar 27, 2026, 9:51 AM EDT
Source: Reuters
Importance Score:
7
BIO-Key International Forecasts 7-Cent Loss Per Share, Revenue Expected to Surge 50%
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 16, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
7
BIO-key Files Definitive Proxy for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article
BKYI
Mar 06, 2026, 5:00 PM EST
Filing Type: PRE 14A
Importance Score:
8
BIO-key Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article